These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22417931)

  • 1. Lower serum interleukin-2 levels in schizophrenic patients with tardive dyskinesia.
    Liu H; Kang Y; Liang J; Li C; Xiu M; Chen D; Yang F; Wang F; Wu G; Haile CN; Kosten TA; Kosten TR; Zhang XY
    Psychiatry Res; 2012 Jul; 198(2):329-31. PubMed ID: 22417931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered IL-2, IL-6 and IL-8 serum levels in schizophrenia patients with tardive dyskinesia.
    An HM; Tan YL; Shi J; Wang ZR; Soars JC; Wu JQ; Yang FD; Huang XF; Zhang XY
    Schizophr Res; 2015 Mar; 162(1-3):261-8. PubMed ID: 25600548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia.
    Yang YQ; Sun S; Yu YQ; Li WJ; Zhang X; Xiu MH; Chen DC; De Yang F; Liu H; Li C; Kosten TR; Zhang XY
    Neurosci Lett; 2011 Sep; 502(1):37-40. PubMed ID: 21798311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Tan YL; Zhou DF; Zhang XY
    Schizophr Res; 2005 May; 74(2-3):263-70. PubMed ID: 15722005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.
    Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY
    Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced serum TNF alpha level in chronic schizophrenia patients with or without tardive dyskinesia.
    Tian L; Tan Y; Chen D; Lv M; Tan S; Soares JC; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():259-64. PubMed ID: 24995685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mn-superoxide dismutase activity is associated with orofacial involuntary movements in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Soares JC; Zhang XY
    Hum Psychopharmacol; 2015 Jan; 30(1):57-63. PubMed ID: 25572310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Zhang XY; Xiu MH; Chen DC; Zhu FY; Wu GY; Haile CN; Lu L; Kosten TA; Kosten TR
    J Psychiatr Res; 2010 May; 44(7):429-33. PubMed ID: 19932492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of altered CuZn superoxide dismutase and cognitive impairment in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Tan S; Wang Z; Yang F; Soares JC; Zhang XY
    J Psychiatr Res; 2014 Nov; 58():167-74. PubMed ID: 25151339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridoxal plasma level in schizophrenic and schizoaffective patients with and without tardive dyskinesia.
    Miodownik C; Meoded A; Libov I; Bersudsky Y; Sela BA; Lerner V
    Clin Neuropharmacol; 2008; 31(4):197-203. PubMed ID: 18670243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced status of plasma total antioxidant capacity in schizophrenia with tardive dyskinesia.
    Chen DC; Xiu MH; Liu H; Zhang BS; Wang Y; Kosten TR; Zhang XY
    J Psychiatr Res; 2010 Nov; 44(15):1111-2. PubMed ID: 20398909
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
    Novick D; Haro JM; Bertsch J; Haddad PM
    J Clin Psychopharmacol; 2010 Oct; 30(5):531-40. PubMed ID: 20814320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia and deficit schizophrenia.
    Telfer S; Shivashankar S; Krishnadas R; McCreadie RG; Kirkpatrick B
    Acta Psychiatr Scand; 2011 Nov; 124(5):357-62. PubMed ID: 21838740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Blood Biochemical Markers with Tardive Dyskinesia in Schizophrenic Patients.
    Wu Q; Yuan F; Zhang S; Liu W; Miao Q; Zheng X; Lu S; Hou K
    Dis Markers; 2022; 2022():1767989. PubMed ID: 35299866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients.
    Singh B; Bera NK; Nayak CR; Chaudhuri TK
    Cytokine; 2009 Jul; 47(1):1-5. PubMed ID: 19502081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis.
    Fallon P; Dursun SM
    J Psychopharmacol; 2011 Jun; 25(6):755-62. PubMed ID: 20147573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients.
    Kang SG; Choi JE; An H; Park YM; Lee HJ; Han C; Kim YK; Kim SH; Cho SN; Joe SH; Jung IK; Kim L; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1844-7. PubMed ID: 18790709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
    Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
    Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.